12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. Gainers included icad (ICAD), Evelo Biosciences (EVLO), Biophytis (BPTS), Hyperfine (HYPR), Marker Therapeutics (MRKR), and Cyclacel Pharmaceuticals (CYCC). Losers included 9 Meters Biopharma (NMTR), Lixte Biotech Hldgs (LIXT), Apellis Pharmaceuticals (APLS), CEL-SCI (CVM), Acumen Pharmaceuticals (ABOS), and Aptevo Therapeutics (APVO).
July 18, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acumen Pharmaceuticals shares decreased by 23.34% to $7.45.
The decrease in Acumen Pharmaceuticals' share price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Apellis Pharmaceuticals stock decreased by 26.5% to $38.56.
The significant decrease in Apellis Pharmaceuticals' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Aptevo Therapeutics shares decreased by 22.54% to $1.1.
The drop in Aptevo Therapeutics' share price is expected to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
CEL-SCI shares declined by 23.78% to $2.18.
The decline in CEL-SCI's share price is expected to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Lixte Biotech Hldgs shares decreased by 29.35% to $5.32.
The substantial drop in Lixte Biotech Hldgs' share price is expected to negatively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
9 Meters Biopharma stock decreased by 68.0% to $0.2 during Tuesday's regular session.
The significant decrease in 9 Meters Biopharma's stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Biophytis stock increased by 29.86% to $2.87.
The significant increase in Biophytis' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cyclacel Pharmaceuticals stock rose 15.61% to $0.66.
The increase in Cyclacel Pharmaceuticals' stock price is expected to positively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Evelo Biosciences shares moved upwards by 30.98% to $4.65.
The substantial rise in Evelo Biosciences' share price is expected to positively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Hyperfine shares moved upwards by 29.48% to $3.03.
The substantial rise in Hyperfine's share price is expected to positively impact its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
icad shares moved upwards by 69.7% to $3.5 during Tuesday's regular session.
The significant increase in icad's share price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Marker Therapeutics shares rose 16.3% to $5.89.
The rise in Marker Therapeutics' share price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100